Skip to main content
Signal8

Weichselbaum Alan

SEC insider (Form 3/4/5 filer). CIK 0001435390. Director at Finwise Bancorp (FINW) and 2 other issuers. 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2026. Located in MURRAY, UT.

Companies Weichselbaum Alan has filed insider reports for

  • Finwise Bancorp (FINW): Director
  • Telomir Pharmaceuticals, Inc. (TELO): Officer, Chief Financial Officer
  • MIRA PHARMACEUTICALS, INC. (MIRA): Officer, Chief Financial Officer
Weichselbaum Alan profile photo

Weichselbaum Alan

CIK: 0001435390

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Finwise Bancorp logo
FINW

Finwise Bancorp

Director
Telomir Pharmaceuticals, Inc. logo
TELO

Telomir Pharmaceuticals, Inc.

Officer
MIRA PHARMACEUTICALS, INC. logo
MIRA

MIRA PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Finwise Bancorp logo
    FINW

    Finwise Bancorp

    Mar 31, 2026
    Award
    Direct
    3.2K shares at avg. $15.73$50K
  • Finwise Bancorp logo
    FINW

    Finwise Bancorp

    May 27, 2025
    Award
    Direct
    2.7K shares at avg. $14.70$40K

1-2 of 2